Atlas Trials

IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Clinical trial NCT07585071 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07585071
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Hemolytic AnemiaRelapsed/Refractory
Start date
2026-06-15
Primary completion
2026-12-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.